A lawsuit against SmithKline Beecham Corp. over the suicide of 23-year-old Tricia Mason, who ended her life two days after taking the antidepressant Paxil, can go forward, the 7th Circuit ruled this week.
In a unanimous Tuesday decision reversing the lower court, the appeals court said that the drug manufacturer now known as GlaxoSmithKline didn’t meet its burden of showing with "clear evidence" that the Food and Drug Administration would have rejected a change in the drug’s labeling to warn about the enhanced possibility of suicide in young adults.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]